Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office
Chubb
Daiichi Sankyo
Healthtrust
Federal Trade Commission

Generated: July 16, 2019

DrugPatentWatch Database Preview

Litigation Details for DEPOMED, INC. v. ACTAVIS ELIZABETH LLC (D.N.J. 2012)

Try a free trialSee Plans and Pricing

« Back to Dashboard

DEPOMED, INC. v. ACTAVIS ELIZABETH LLC (D.N.J. 2012)

Docket ➤ Try a Free Trial Date Filed 2012-03-02
Court District Court, D. New Jersey Date Terminated 2014-08-19
Cause 35:145 Patent Infringement Assigned To Mary Little Cooper
Jury Demand Defendant Referred To Magistrate Judge Tonianne J. B
Parties ABON PHARMACEUTICALS, LLC; ACTAVIS ELIZABETH LLC; ACTAVIS LLC; ACTAVIS, INC.; DEPOMED, INC.; INCEPTA PHARMACEUTICALS CO. LTD.; WATSON LABORATORIES, INC. - FLORIDA; WATSON PHARMA, INC.; WATSON PHARMACEUTICALS, INC.
Patents 5,972,389; 6,054,482; 6,340,475; 6,488,962; 6,635,280; 6,723,340; 7,438,927; 7,731,989; 8,192,756; 8,252,332; 8,333,992
Attorneys ARNOLD B. CALMANN; ELEONORE OFOSU-ANTWI; GREGORY J. BEVELOCK; GREGORY SCOTT TABAKMAN; JAKOB BENJAMIN HALPERN; JAMES S. RICHTER; LEDA DUNN WETTRE; LIZA M. WALSH; MELISSA STEEDLE BOGAD; MICHAEL JAMES GESUALDO; ROBERT JOSEPH FETTWEIS; TRICIA B. O'REILLY; VALENTINA SHENDEROVICH; WATSON LABORATORIES, INC. - FLORIDA
Link to Docket External link to docket
Small Molecule Drugs cited in DEPOMED, INC. v. ACTAVIS ELIZABETH LLC

Details for DEPOMED, INC. v. ACTAVIS ELIZABETH LLC (D.N.J. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-03-02 1 Complaint December 3, 2002, United States Patent No. 6,488,962 (the “‘962 Patent”) entitled “Tablet Shapes To Enhance…Gralise® prior to the expiration of U.S. Patent Nos. 6,340,475, 6,488,962, 6,635,280, DM_US 31899826-4.082221.0018… This is an action for patent infringement arising under the patent laws of the United States (… THE PATENTS-IN-SUIT 14. On January 22, 2002, United States Patent No. 6,340,475…October 21, 2003, United States Patent No. 6,635,280 (the “‘280 Patent”) entitled “Extending the Duration External link to document
2013-03-20 155 Answer to Amended Complaint U.S. Patent Nos. 6,340,475, 6,635,280 and 6,723,340 only); and that U.S. Patent Nos. 6,340,475, 6,635,280… United States Patent Nos. 6,340,475 (“the ‘475 patent”), 6,635,280 (“the ‘280 patent”), 7,438,927 (…United States Patent and Trademark Office purportedly issued United States Patent No. 6,340,475 (“the ‘475…475 patent, the ‘962 patent, the ‘280 patent, the ‘340 patent, the ‘927 patent, the ‘989 patent, the…475 patent, the ‘962 patent, the ‘280 patent, the ‘340 patent, the ‘927 patent, the ‘989 patent, the External link to document
2013-12-03 243 Order infringement contentions with respect to U.S. Patent No. 8,333,992 is GRANTED; that Defendants shall serve … 19 August 2014 3:12-cv-01358-MLC-TJB Patent Defendant District Court, D. External link to document
2014-01-28 251 Opinion : U.S. Patent No. 6,340,475 (the “ ‘475 patent”), U.S. Patent No. 6,488,962 (the “ ‘962 patent”), U.S….S. Patent No. 6,635,280 (the “ ‘280 patent”), U.S. Patent No. 7,438,927 (the “ ‘927 patent”), U.S. Patent… Patent No. 7,731,989 (the “ ‘989 patent”), U.S. Patent No. 8,192,756 (the “ ‘756 patent”), and U.S. …. Patent No. 8,252,332 (the “ ‘332 patent”). The ‘475 patent and ‘280 patent are directed towards…” 2 See generally, ‘475 patent and ‘280 patent. As explained in these patents, conventional tablets or External link to document
2014-01-28 252 Order the U.S. Patent No. 6,340,475, U.S. Patent No. 6,488,962, U.S. Patent No. 6,635,280, U.S. Patent No. 7,438,927…,438,927, U.S. Patent No. 7,731,989, U.S. Patent No. 8,192,756, and U.S. Patent No. 8,252,332 shall be… 19 August 2014 3:12-cv-01358-MLC-TJB Patent Defendant District Court, D. External link to document
2012-03-30 26 Amended Complaint Gralise® prior to the expiration of U.S. Patent Nos. 6,340,475, 6,488,962, 6,635,280, …. 6,488,962 (the “‘962 Patent”) entitled “Tablet Shapes To Enhance Gastric Retention of Swellable Controlled-Release…. This is an action for patent infringement arising under the patent laws of the United States (… THE PATENTS-IN-SUIT 30. On January 22, 2002, United States Patent No. 6,340,475…475 Patent is attached as Exhibit 1.) 31. On December 3, 2002, United States Patent No. External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Medtronic
Healthtrust
Citi
Merck
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.